Mitchum et al. showed that ablation of CCR2 or CSF-1R signaling significantly blocked TAM infiltration in pancreatic ductal adenocarcinoma (PDAC), reduced the number of CD44 + ALDH1 + CSCs, and improved the response to chemotherapy67. The gene discussed is ALDH1A1; the disease is pancreatic ductal adenocarcinoma.